Roger B Cohen Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

1/2022	Platinum Re-Exposure as a Non-Small Cell Lung Cancer (NSCLC) Treatment Strategy in the Age of Immunotherapy.
1/2022	Phase II Trial of Combination Nab-paclitaxel and Gemcitabine in Non-squamous Non-small Cell Lung Cancer After Progression on Platinum and Pemetrexed.
1/2022	Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial.
1/2021	Outcomes in Patients With Non-small-cell Lung Cancer With Brain Metastases Treated With Pembrolizumab-based Therapy.
1/2021	Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor-Based Therapy in Patients With Advanced Non-Small-Cell Lung Cancer.
1/2021	Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based Therapy.
1/2020	Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer.
1/2020	Early Tumor and Nodal Response in Patients with Locally Advanced Non-Small Cell Lung Carcinoma Predict for Oncologic Outcomes in Patients Treated with Concurrent Proton Therapy and Chemotherapy.
9/2019	Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer: A Phase 2 Trial.
1/2019	Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roger B Cohen Research Topics

Disease

78	Neoplasms (Cancer) 05/2022 - 05/2005
32	Squamous Cell Carcinoma of Head and Neck 05/2022 - 01/2004
26	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 06/2007
18	Head and Neck Neoplasms (Head and Neck Cancer) 05/2022 - 05/2005
10	Disease Progression 01/2020 - 02/2006
9	Neutropenia 10/2021 - 10/2007
8	Lung Neoplasms (Lung Cancer) 09/2020 - 09/2008
8	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018 - 10/2007
7	Oropharyngeal Neoplasms 12/2021 - 01/2016
7	Fatigue 12/2017 - 04/2007
6	Squamous Cell Neoplasms (Squamous Cell Cancer) 10/2021 - 09/2006
6	Febrile Neutropenia 01/2019 - 10/2007
6	Thrombocytopenia (Thrombopenia) 01/2019 - 09/2009
6	Diarrhea 10/2017 - 06/2007
5	Melanoma (Melanoma, Malignant) 01/2022 - 02/2013
5	Exanthema (Rash) 12/2017 - 09/2006
5	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 02/2003
4	Nausea 01/2016 - 09/2009
3	Anemia 10/2021 - 09/2009
3	Neoplasm Metastasis (Metastasis) 10/2021 - 10/2007
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2019 - 08/2014
3	Pain (Aches) 10/2019 - 03/2010
3	Mucositis 10/2017 - 07/2011
3	Fever (Fevers) 01/2017 - 04/2007
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2015 - 09/2009
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 09/2009
2	Sepsis (Septicemia) 03/2021 - 12/2017
2	Brain Neoplasms (Brain Tumor) 01/2021 - 01/2018
2	Adenocarcinoma 01/2021 - 03/2010
2	Extranodal Extension 01/2020 - 05/2017
2	Margins of Excision 01/2020 - 05/2017
2	Hypertension (High Blood Pressure) 01/2018 - 10/2008
2	Edema (Dropsy) 12/2016 - 12/2015
2	Hypersensitivity (Allergy) 05/2014 - 09/2009

Drug/Important Bio-Agent (IBA)

16	Cetuximab (Erbitux)FDA Link 05/2022 - 02/2006
11	Monoclonal AntibodiesIBA 05/2022 - 02/2006
10	pembrolizumabIBA 01/2022 - 01/2017
9	PlatinumIBA 01/2022 - 09/2007
9	Carboplatin (JM8)FDA LinkGeneric 01/2019 - 06/2007
9	Pharmaceutical PreparationsIBA 01/2019 - 01/2007
9	ErbB Receptors (EGF Receptor)IBA 01/2018 - 02/2003
8	Biomarkers (Surrogate Marker)IBA 05/2022 - 02/2011
8	Cisplatin (Platino)FDA LinkGeneric 10/2021 - 05/2005
8	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 01/2004
8	Docetaxel (Taxotere)FDA Link 01/2019 - 10/2007
6	Gemcitabine FDA Link 01/2022 - 09/2008
6	AZD 6244IBA 10/2017 - 05/2008
5	B7-H1 AntigenIBA 01/2022 - 01/2017
5	Immune Checkpoint InhibitorsIBA 12/2021 - 12/2019
5	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2017 - 02/2013
5	temsirolimus FDA Link 10/2017 - 11/2007
5	Lapatinib (GW572016)FDA Link 01/2016 - 09/2007
3	Pemetrexed (MTA)FDA Link 01/2022 - 01/2017
3	AntigensIBA 01/2021 - 09/2009
3	LigandsIBA 01/2020 - 12/2016
3	Biological ProductsIBA 09/2019 - 09/2007
3	RamucirumabIBA 01/2019 - 02/2010
3	AntibodiesIBA 01/2019 - 12/2006
3	Circulating Tumor DNAIBA 01/2019 - 12/2016
3	Fluorouracil (Carac)FDA LinkGeneric 01/2016 - 10/2007
3	Tyrosine Kinase InhibitorsIBA 05/2014 - 08/2009
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2013 - 05/2008
3	Aurora Kinase AIBA 09/2012 - 02/2011
3	IodineIBA 04/2012 - 10/2008
2	VaccinesIBA 01/2021 - 05/2016
2	DNA (Deoxyribonucleic Acid)IBA 08/2020 - 12/2016
2	Bevacizumab (Avastin)FDA Link 01/2019 - 05/2014
2	EnzymesIBA 01/2019 - 02/2016
2	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2019 - 02/2016
2	Phosphotransferases (Kinase)IBA 01/2019 - 04/2010
2	pevonedistatIBA 01/2019 - 02/2016
2	Calcibiotic Root Canal SealerIBA 01/2017 - 02/2003
2	Dacarbazine (DIC)FDA LinkGeneric 01/2017 - 02/2013
2	Activin Receptors (Activin Receptor)IBA 12/2016 - 01/2016
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2016 - 08/2015
2	Lipase (Acid Lipase)FDA Link 01/2016 - 07/2011
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2015 - 11/2009
2	Axitinib (AG 013736)IBA 01/2015 - 10/2008
2	Sunitinib (Sutent)FDA Link 01/2015 - 09/2011
2	AfatinibIBA 05/2014 - 04/2013
2	MLN 8237IBA 05/2014 - 09/2012
2	Panitumumab (Vectibix)FDA Link 05/2014 - 01/2009
2	Mitogen-Activated Protein KinasesIBA 03/2014 - 04/2010
2	Dihydrotachysterol (AT 10)IBA 04/2013 - 09/2009
2	thiamine triphosphorate (TTP)IBA 02/2013 - 03/2010
2	MLN8054IBA 04/2011 - 02/2011
2	Aurora KinasesIBA 02/2011 - 11/2009
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 11/2009 - 11/2009

Therapy/Procedure

55	Therapeutics 04/2022 - 01/2007
27	Drug Therapy (Chemotherapy) 01/2022 - 05/2005
24	Radiotherapy 01/2022 - 02/2006
11	Immunotherapy 01/2022 - 05/2016
5	Induction Chemotherapy 01/2018 - 10/2007
4	Chemoradiotherapy 10/2021 - 10/2007
3	Neck Dissection (Radical Neck Dissection) 12/2019 - 03/2010
3	Cranial Irradiation 01/2018 - 10/2007
2	Aftercare (After-Treatment) 12/2021 - 06/2007
2	Adjuvant Chemoradiotherapy 10/2021 - 05/2017
2	Proton Therapy 01/2020 - 11/2017
2	Adjuvant Radiotherapy 12/2019 - 05/2017